Alumni raised $1.45B in 2022 - Download Free Report Now

Mesynthes

Extracellular matrix (ECM) implant that is completely integrated, remodeled, and replaced by the patient’s native tissue over time.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Mesynthes plus 5517 other startups.

Start Free 7 Day Trial Now

Learn More About Mesynthes

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More

Companies We Work With